Global Onychomycosis Drug Market Companies

Pharmaceutical
May 2025
Global
350 Pages
No of Tables: 220
No of Figures: 60

Buy Now

Request for Sample

Nucleus

Companies Covered

Highest Market Share

Dominant Companies

Other Companies

Global Onychomycosis Drug Market Share Analysis

The data presented is for visualization purposes only and may not reflect actual results.

Nucleus : Company Analysis Platform

Request for Demo >

Frequently Asked Questions

Who are major players in the Onychomycosis Drug Market?

Major companies include Pfizer Inc. (U.S.), Novartis AG (Switzerland), Bausch Health Companies Inc. (Canada), Moberg Pharma AB (Sweden), Glenmark Pharmaceuticals Ltd. (India), and Dr. Reddy's Laboratories Ltd. (India).

What are the recent product launches by major companies in the Onychomycosis Drug Market?

In February 2024, Allderma AB introduced the Terclara brand for the sale of MOB-015, effective in the treatment of onychomycosis across the European region.

Which countries' data is covered in the Onychomycosis Drug Market?

The countries covered in the onychomycosis drug market include U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and rest of Middle East and Africa.